3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
13
Lung Neoplasms
12
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
7
Carcinoma, Renal Cell
6
Urinary Bladder Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neuroblastoma
4
Glioblastoma
4
Colorectal Neoplasms
4
Brain Neoplasms
4
Small Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Ganglioneuroblastoma
3
Disease
3
Carcinoma, Hepatocellular
3
Carcinoma
3
Ureteral Neoplasms
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Mantle-Cell
2
Interventions
Mitomycin
12
Gemcitabine
9
BCG Vaccine
4
apaziquone
3
Epirubicin
3
erdafitinib
2
durvalumab
2
dodecyl maltoside
2
VB4-845
2
Docetaxel
2
viscum album peptide
1
valrubicin
1
pirarubicin
1
hydroxycamptothecinum
1
Transurethral Resection of Bladder
1
Therapeutic Uses
1
Standard of Care
1
Saline Solution
1
Radiotherapy
1
Polysorbates
1
Maintenance
1
Magnetic Resonance Spectroscopy
1
Injections
1
Cystoscopy
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled